| ISIN | CH0209545562 |
|---|---|
| Valor Number | 20954556 |
| Bloomberg Global ID | BBG004FYZ1R0 |
| Fund Name | Swiss Rock Aktien Schweiz Index Plus B |
| Fund Provider |
Swiss Rock Asset Management AG
Zürich, Switzerland Phone: +41 44 360 57 00 E-Mail: info@swiss-rock.ch Web: www.swiss-rock.ch |
| Fund Provider | Swiss Rock Asset Management AG |
| Representative in Switzerland | |
| Distributor(s) |
Swiss Rock Asset Management AG Zürich Phone: +41 44 360 57 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
| Investment Strategy *** | n/a |
| Peculiarities |
| Current Price * | 22.40 CHF | 17.11.2025 |
|---|---|---|
| Previous Price * | 22.50 CHF | 14.11.2025 |
| 52 Week High * | 22.80 CHF | 12.11.2025 |
| 52 Week Low * | 18.91 CHF | 09.04.2025 |
| NAV * | 22.40 CHF | 17.11.2025 |
| Issue Price * | 22.43 CHF | 17.11.2025 |
| Redemption Price * | 22.38 CHF | 17.11.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 69,689,725 | |
| Unit/Share Assets *** | 42,165,095 | |
| Trading Information SIX | ||
| YTD Performance | +11.71% |
30.12.2024 - 17.11.2025
30.12.2024 17.11.2025 |
|---|---|---|
| 1 month | -0.04% |
17.10.2025 - 17.11.2025
17.10.2025 17.11.2025 |
| 3 months | +3.28% |
18.08.2025 - 17.11.2025
18.08.2025 17.11.2025 |
| 6 months | +2.99% |
19.05.2025 - 17.11.2025
19.05.2025 17.11.2025 |
| 1 year | +11.39% |
18.11.2024 - 17.11.2025
18.11.2024 17.11.2025 |
| 2 years | +18.59% |
17.11.2023 - 17.11.2025
17.11.2023 17.11.2025 |
| 3 years | +18.84% |
17.11.2022 - 17.11.2025
17.11.2022 17.11.2025 |
| 5 years | +26.95% |
17.11.2020 - 17.11.2025
17.11.2020 17.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 12.22% | |
|---|---|---|
| Roche Holding AG | 11.87% | |
| Nestle SA | 10.90% | |
| Zurich Insurance Group AG | 5.79% | |
| UBS Group AG Registered Shares | 5.08% | |
| Compagnie Financiere Richemont SA Class A | 4.63% | |
| ABB Ltd | 4.48% | |
| Swiss Re AG | 3.42% | |
| Holcim Ltd | 2.93% | |
| Geberit AG | 2.05% | |
| Last data update | 31.07.2025 | |
| TER | 0.40% |
|---|---|
| TER date | 30.06.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.55% |
| Ongoing Charges *** | 0.39% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |